Breaking News

iuvo BioScience Acquires Promedica International

To support customers from the early preclinical and lab stages through all phases of clinical development.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

iuvo BioScience, a specialty PRO (Partner Research Organization) providing preclinical and clinical development services, lab services, and scientific consulting, has acquired Promedica International, a California Corp. (PMI), a specialty ophthalmology-focused clinical CRO. The combined organization will support all aspects of ophthalmic clinical research, from front of the eye to back of the eye, leveraging an even larger team of experts in ophthalmology.   As part of the transaction, iuvo ha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters